Patent · US Expired

Acylated arylcycloalkylamines and their use as pharmaceuticals

US7186735B2 · kind B2 · utility

59Cited by

9References

7Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Hartmut Strobel · Liederbach, DE
Paulus Wohlfart · Frankfurt am Main, DE
Peter Below · Frankfurt, DE

Key dates

Filing date	Aug 7, 2003
Grant date	Mar 6, 2007
Priority date	—
Expiry date	Jun 3, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/02
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to acylated arylcycloalkylamines, to pharmaceutical compositions comprising such compounds, to methods for the stimulation of the expression of endothelial NO synthase, and methods of treatment comprising administering such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.